Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12,110 GBX | -0.46% | -2.10% | +14.25% |
May. 17 | Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial | RE |
May. 16 | AstraZeneca's Sipavibart Prevents COVID-19 in Immunocompromised Patients in Phase 3 Trial | MT |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC